Mondelez is the low-volatility anchor of the basket — a defensive snacking staple built on Oreo and Cadbury, with genuine pricing power and a beta of just 0.40 Yahoo Finance· live. Four straight adjusted-EPS beats show it is executing through a cocoa-driven earnings trough — though be honest about the trade-off: at ~19x forward earnings the valuation is full for a name whose 2026 adjusted EPS is guided only flat to +5% in constant currency, so this is a defensive total-return hold (3.2% yield + buyback), not a cheap growth story. Crucially, the stock is not over-extended — it sits just +1.7% above a rising EMA20, making this an actionable entry rather than a chase.
Mondelez International is one of the world's largest snacking companies, generating $38.5B of net revenue in FY2025 across biscuits (Oreo, Ritz, belVita, LU), chocolate (Cadbury, Milka, Toblerone), gum and candy SEC 8-K FY25· fév 2026. The portfolio is anchored by power brands that hold the #1 or #2 position in most categories and geographies, giving Mondelez durable shelf space and the ability to push price.
Geographically the business is genuinely global — Europe, North America, Latin America, and a fast-growing AMEA (Asia, Middle East & Africa) segment. That diversification is the source of the defensive profile: when one region softens, another absorbs the slack. The flip side is FX exposure, since a large share of profit is earned in non-USD currencies. The moat is brand equity plus distribution scale — hard to replicate, and the reason snacking volumes prove sticky across economic cycles.
| Metric | Value | Signal |
|---|---|---|
| Revenue (FY25) | $38.5B | Resilient |
| Q1'26 Revenue | $10.08B | +8.2% YoY |
| Gross Margin (FY25) | 30.5% | 27.8% in Q1'26 (cocoa) |
| Operating Margin | 11.9% | Healthy |
| Net Margin | ~12% | Solid |
| ROE | ~18% | High quality |
| Free Cash Flow | ~$3.2B | Funds buyback + div |
| EV / EBITDA | 19.7x | Premium staple |
| P/B | 3.2x | Brand-heavy |
| Fwd P/E | ~19x | In-line w/ peers |
| 2026 Adj. EPS Guide | Flat to +5% cc | Trough, not growth |
| Analyst Target (avg) | ~$66–70 | +5–11% / Buy |
The story in one line: a high-ROE staple absorbing a cocoa shock at a full multiple. Gross margin slipped to 27.8% in Q1 2026 from a ~30.5% FY25 base under input-cost inflation. Mondelez priced through it on the top line — Q1 revenue grew +8.2% to $10.08B — but adjusted EPS still fell to $0.67, down 14.9% in constant currency even as it beat the ~$0.61 consensus SEC 8-K Q1'26· avr 2026. Management guides 2026 adjusted EPS to flat-to-+5% cc — this is an earnings trough, not a growth story, so at ~19x forward earnings the multiple is fair-to-full, not cheap. The bull case is total return: roughly $3.2B of free cash flow comfortably covers both the buyback and the dividend, and with a ~$66–70 Buy-consensus target and a 3.2% yield the math still works for a 0.40-beta defensive anchor.
| RSI (14) | 58.8 |
| EMA 20 | $61.94 |
| EMA 50 | $60.69 |
| EMA 200 | $60.05 |
| MACD | 0.740 |
| Signal | 0.630 |
| ATR (14) | $1.30 |
Clean, controlled uptrend. EMA20 ($61.94) > EMA50 ($60.69) > EMA200 ($60.05) — all three rising and stacked in the right order, with price riding just +1.7% above the EMA20 Finviz· live. RSI 58.8 is mid-range momentum — room to run before overbought. MACD 0.74 holds above its 0.63 signal. ATR is only $1.30 (~2.1% of price), confirming the low-volatility character and allowing a tight, well-defined stop just under the EMA50. This is a name to accumulate near support, not chase into extension.
This is the inverse of a dilution risk — Mondelez is a serial returner of capital. The board authorized a $9 billion share repurchase program effective Jan 2025, a 50% increase over the prior $6B authorization, running through end-2027 StockTitan· 2026. Diluted share count is flat-to-declining at ~1,286M, and the company has raised its dividend for 14 consecutive years to a $2.00 annualized rate StockAnalysis· 2026. A universal S-3ASR shelf was refreshed in Feb 2026 — standard for a well-known seasoned issuer of this size — but it has been used only as a framework for routine debt issuance, with no equity sold under it SEC S-3ASR· fév 2026.
A defensive, investment-grade staple with a 0.40 beta and a clean capital structure. The dominant risk is operational — cocoa-driven margin pressure — not balance-sheet or dilution risk.
Mondelez carries a 3/10 risk score because the danger is concentrated in one well-understood, partially-hedgeable line item — cocoa — rather than the balance sheet. There is no dilution overhang, no toxic financing, no execution cliff. With beta 0.40, investment-grade credit, and four straight beats, the downside is shallow and the franchise is among the most defensive in the market MarketBeat· jun 2026.
This is an actionable-at-spot setup, not a chase. With price at $62.99 just above a rising EMA20, you enter at $62.50, risk to $60.40 (just under the EMA50 cluster, ~1.6× ATR), and target the next structure at $66.00. That produces R/R = (66.00 − 62.50) / (62.50 − 60.40) = 3.50 / 2.10 = 1.67, comfortably above the 1.5 threshold at an entry within 1% of the live price. TP2 at $69.00 stretches toward the upper end of the ~$66–70 analyst-consensus band. The low ATR means the tight stop is realistic, and the 0.40 beta means this position bleeds slowly even when the broad tape turns red.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from DailyTickers Gateway, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.